The − 279/+ 5 promoter displayed significant cancer-specific killing across all cell lines compared to CMV for both p53-Bad and p53-Bad*, though p53-Bad* showed higher killing overall—particularly in Skov3 cells—as well as a greater difference between cancer cells and normal cells (Fig. 10). This evidence concerns the gene BAD and cancer.